Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Ocular Surface Disease Changes After iStent or iStent Inject Trabecular Micro-Bypass Implantation With Cataract Surgery

NCT04452279 is registered in ClinicalTrials.gov with Vance Thompson Vision as lead sponsor.

NCT NCT04452279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Ocular Surface Disease Changes After iStent or iStent Inject Trabecular Micro-Bypass Implantation With Cataract Surgery
Lead sponsor
Vance Thompson Vision
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2018
Completion date
August 15, 2019
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, ocular surface disease